Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells
Cancer Research UK Scotland Institute · University of Glasgow · +2 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
553
total citations
- FWCI
- 29.15
- Percentile
- 100%
- References
- 25
Citations per year
Authors
8Topics & keywords
Topics
Keywords
- Stem cell
- Myeloid leukemia
- Cancer research
- Imatinib mesylate
- CD38
- Medicine
- Leukemia
- CD34
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- BSBristol-Myers Squibb
- AAstraZeneca
- LLeuka
- CRCancer Research UKAwards: C596/A18076, A18076, C596/A17196, A17196
- KKKay Kendall Leukaemia FundAwards: KKL698, KKL501
- IEImperial Experimental Cancer Medicine Centre
- MRMedical Research CouncilAwards: MR/K014854/1, MR/K014854/1
- BIBeatson Institute for Cancer ResearchAwards: C596/A17196, A17196